Probiotic-derived silver nanoparticles target mTOR/MMP-9/BCL-2/dependent AMPK activation for hepatic cancer treatment.

Autor: Elmetwalli A; Department of Clinical Trial Research Unit and Drug Discovery, Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt. dr.prof2011@gmail.com.; Microbiology Division, Higher Technological Institute of Applied Health Sciences, Egyptian Liver Research Institute and Hospital (ELRIAH), Mansoura, Egypt. dr.prof2011@gmail.com., Abdel-Monem MO; Botany and Microbiology Department, Faculty of Science, Benha University, Benha, Egypt., El-Far AH; Department of Biochemistry, Faculty of Veterinary Medicine, Damanhour University, Damanhour, 22511, Egypt., Ghaith GS; Botany and Microbiology Department, Faculty of Science, Benha University, Benha, Egypt., Albalawi NAN; Department of Nursing, Al Hadithah General Hospital, Al Qurayyat, Saudi Arabia., Hassan J; Department of Applied Medical Chemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt., Ismail NF; Health Information Management Program, Biochemistry, Faculty of Health Science Technology, Borg El Arab Technological University, Alexandria, Egypt., El-Sewedy T; Department of Applied Medical Chemistry, Medical Research Institute, Alexandria University, Alexandria, Egypt., Alnamshan MM; Biology Department, College of Science, Imam Abdulrahman Bin Faisal University, 31441, Dammam, Saudi Arabia., ALaqeel NK; Biology Department, College of Science, Imam Abdulrahman Bin Faisal University, 31441, Dammam, Saudi Arabia., Al-Dhuayan IS; Biology Department, College of Science, Imam Abdulrahman Bin Faisal University, 31441, Dammam, Saudi Arabia., Hassan MG; Botany and Microbiology Department, Faculty of Science, Benha University, Benha, Egypt.

Publikováno v: Medical oncology (Northwood, London, England) [Med Oncol] 2024 Apr 04; Vol. 41 (5), pp. 106. Date of Electronic Publication: 2024 Apr 04.